Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of GSK's DTPa-IPV vs DTPa + IPV in Healthy Infants
NCT00290342Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2006
- Primary completion
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of diphtheria toxoid + tetanus toxoid + acellular pertussis + inactivated poliovirus vaccine in diphtheria, Tetanus, pertussis, poliomyelitis, sponsored by GSK. Started Jan 2006; status: completed.
02
Drugs
diphtheria toxoid + tetanus toxoid + acellular pertussis + inactivated poliovirus vaccine
03
Conditions
diphtheriaTetanuspertussispoliomyelitis
Beyond the preview
Go deeper on NCT00290342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00290342.